Ireland vs Moldova: Colon and rectum cancer screening coverage in Europe
Ireland
43.9%
in 2024
Moldova
44.6%
in 2024
Ireland rank
10th
Moldova rank
9th
Colon and rectum cancer screening coverage in Europe over time
- Ireland
- Moldova
How they compare
Moldova currently reports 44.6% against 43.9% in Ireland, a difference of 0.7%.
The two have swapped places 3 times across 8 shared years of data; in 2017 it was Ireland ahead.
Ireland ranks 10th and Moldova ranks 9th of 20 countries.
Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ireland | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.5% | 41.7% | 0.8% | Ireland |
| 2020s | 45.8% | 39.2% | 6.6% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Ireland or Moldova?
- Moldova, at 44.6% against 43.9% in Ireland as of 2024.
- What is the difference in colon and rectum cancer screening coverage in europe between Ireland and Moldova?
- 0.7%, with Moldova ahead.
- How many years of comparable data are there for Ireland and Moldova?
- 8 years are reported by both, from 2017 to 2024.
- How do Ireland and Moldova rank globally for colon and rectum cancer screening coverage in europe?
- Ireland ranks 10th and Moldova ranks 9th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.